Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Zymo Research recibió la marca CE IVD para dispositivos de recolección de muestras
  • USA - español
  • India - English
  • Brazil - Português
  • USA - Deutsch
  • USA - Français

Zymo Research Corp. Logo

News provided by

Zymo Research Corp.

Sep 28, 2020, 15:46 ET

Share this article

Share toX

Share this article

Share toX

Conservación segura y confiable de muestras a temperatura ambiente para aplicaciones IVD

IRVINE, California, 28 de septiembre de 2020 /PRNewswire/ -- Zymo Research anunció que tres de sus dispositivos de recolección DNA/RNA Shield™: 1) Tubo de recolección con hisopo DNA/RNA Shield™, 2) Kit de recolección de saliva/esputoDNA/RNA Shield™ y 3) Tubo de recolección fecal DNA/RNA Shield™ ahora cuentan con la marca CE IVD para aplicaciones de diagnóstico in vitro (IVD, por su sigla en inglés).

Continue Reading
Zymo Research recibió la marca CE IVD para su reactivo y dispositivos de recolección DNA/RNA Shield™
Zymo Research recibió la marca CE IVD para su reactivo y dispositivos de recolección DNA/RNA Shield™

La línea de productos DNA/RNA Shield™ incluye dispositivos de recolección, conservación y transporte de muestras para especímenes médicos utilizados en la investigación y ahora se encuentran disponibles para diagnósticos in vitro (por ejemplo, para pruebas de COVID-19). Para recibir la marca CE IVD, los científicos de Zymo Research recolectaron gran cantidad de información sobre el desempeño a la hora de desactivar muestras (patógenos) y conservar el ácido nucleico. Los resultados confirmaron una estabilidad sin precedentes en las muestras (semanas/meses) y el ADN (varios años) cuando las muestras se almacenan a temperatura ambiente. Ya que DNA/RNA Shield™ desactiva los patógenos inmediatamente, incluyendo el SARS-CoV-2, el virus que causa la COVID-19, el transporte de muestras es mucho más seguro para los profesionales de laboratorio y los trabajadores expuestos.

"Estamos estandarizando la recolección de muestras en los marcos clínicos y de investigación", explicó el Dr. Stanislav Forman de Zymo Research Corp. "Esta tecnología provee un nivel de seguridad tanto para los servicios de emergencia como para los proveedores de servicios; aunque los patógenos están desactivados, los códigos del ácido nucleico se mantienen. La marca CE IVD nos permite apoyar a muchos más laboratorios clínicos y organizaciones a nivel global, incluyendo aquellos que están realizando pruebas de COVID-19 durante la pandemia actual".

La marca CE IVD llega en un momento crítico, ya que muchos laboratorios y organizaciones necesitan dispositivos de recolección de muestras para dar respaldo a los flujos de trabajo de las pruebas de COVID-19. Zymo Research ya respalda los esfuerzos globales a gran escala de las pruebas de COVID-19 con su producto DNA/RNA Shield™, incluyendo el Corona Testing Centre en el aeropuerto de Stuttgart. CeGaT GmbH, un proveedor de servicios de diagnóstico genético y de Secuenciación masiva paralela (NGS) de Tübingen, Alemania, opera el centro de pruebas. Para la prueba se utiliza el tubo de recolección con hisopo DNA/RNA Shield™ para recolectar muestras nasofaríngeas de los pasajeros del aeropuerto, que son escaneadas mediante una prueba de reacción en cadena de la polimerasa en tiempo real (RT-PCR) para detectar el ARN viral del SARS-CoV-2. Los resultados de las pruebas se encuentran disponibles al día siguiente, como parte de los esfuerzos estatales para contener la propagación de la COVID-19.

"Dependemos de los tubos de recolección de muestras de Zymo Research para diagnósticos de SARS-CoV-2 agudos", afirmó la Dra. en medicina y Dra. rer. nat. Saskia Biskup, directora general de Praxis für Humangenetik Tübingen & CeGaT GmbH. "Valoramos las capacidades de desactivación de la solución DNA/RNA Shield™, que nos permite un manejo más seguro de las muestras y, en consecuencia, una mayor productividad en nuestro laboratorio".

Para más información sobre DNA/RNA Shield™ y los dispositivos de recolección, visite la página web de Zymo Research o contáctelos por correo electrónico en [email protected] .

Acerca de Zymo Research Corp.
Zymo Research es una compañía privada que ha estado sirviendo a la comunidad científica y de diagnóstico con herramientas de biología molecular de última generación desde 1994. Su eslogan, "La belleza de la ciencia es simplificar las cosas", se refleja en todos sus productos, desde la epigenética hasta las tecnologías de purificación de ADN/ARN. Históricamente reconocido como líder en epigenética, Zymo Research está rompiendo los límites con soluciones novedosas para la recolección de muestras, mediciones microbiómicas, dispositivos de diagnóstico, y tecnologías NGS de alta calidad y fáciles de usar. Siga a Zymo Research en Facebook, LinkedIn, Twitter e Instagram.

Foto - https://mma.prnewswire.com/media/1282005/DNA_RNA_Shield_Collection_Devices.jpg

Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg

FUENTE Zymo Research Corp.

Related Links

http://www.zymoresearch.com

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Zymo Research and STORI Advance Early Pregnancy Detection with Cell-Free DNA Technology

Zymo Research and STORI Advance Early Pregnancy Detection with Cell-Free DNA Technology

Zymo Research, a global leader in life science technologies, and STORI, a new women's health company, today announced a collaboration to bring a...

Zymo Research Advances Wastewater Surveillance as Sponsor of the Microbes in Wastewater Symposium 2026

Zymo Research Advances Wastewater Surveillance as Sponsor of the Microbes in Wastewater Symposium 2026

Zymo Research Corporation, a global leader in molecular biology and pathogen detection, is proud to sponsor the Microbes in Wastewater Symposium...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.